Acer Therapeutics Inc. (DE) (ACER) Financials

$0.66

$-0.14 (-17.95%)

As on 20-Nov-2023 16:00EDT

Market cap

$16 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

17.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	0.37	--	1.26	--	--	0.43
Cost of Revenue	0.08	--	--	--	--	--
Gross Profit	0.29	--	1.26	--	--	0.43
Operating Expenses	27.71	24.61	17.21	22.80	29.90	21.71
Operating Profit (EBIT)	-17.01	-24.61	-15.95	-22.80	-29.90	-21.71
Other Income	-3.80	--	--	-0.08	0.48	0.43
Profit before Tax	-48.49	-26.24	-15.37	-22.89	-29.42	-21.28
Provision for Tax	17.23	1.62	-0.65	0.01	-0.54	-0.43
Profit after Tax (Net Income)	-60.92	-27.86	-14.73	-22.90	-28.88	-21.28
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-8.09	--	-15.37	-22.89	-29.42	-21.28

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-47.74	-16.76	-1.72	8.22	18.37	45.08
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	76.69	9.43	8.87	0.24	0.33	1.03
Current Liabilities	61.67	18.95	29.11	6.15	2.77	5.58
Total Liabilities	14,063.74	11.62	36.26	14.61	21.47	50.66

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	7.86	8.11	8.17	8.17	8.58	7.92
Current Assets	6.14	3.52	28.09	6.44	12.88	42.75
Total Assets	20.14	11.62	36.26	14.61	21.47	50.66
Total Debt*	18.15	11.86	0.39	0.36	0.59	--
Net Current Assets	--	-15.44	-1.02	0.30	10.12	37.17

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-30.25	-0.13	-17.03	-29.51	-16.59
Cash Flow from Investing Activities	--	--	-0.05	-0.01	-0.18	-0.10
Cash from Financing Activities	--	20.04	0.01	10.72	0.00	42.71
Net Cash Inflow / Outflow	--	--	--	-6.32	-29.59	26.03

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-2.93	-1.74	-1.05	-2.08	-2.89	-2.36
Cash EPS ($)	--	-1.74	-1.05	-2.08	-2.88	-2.36
Adjusted Book Value ($)	--	--	--	0.75	1.84	5.01
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.89	-0.01	-1.55	-2.95	-1.84
Free Cash Flow per Share ($)	--	-1.90	-0.01	-1.55	-2.97	-1.85

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	894.87	-405.81	-166.23	-90.19	-63.13
ROE (%)	--	301.44	-453.14	-172.19	-91.03	-63.13
ROA (%)	-216.56	-116.37	-57.91	-126.93	-80.08	-56.72
EBIT Margin (%)	-3,716.22	--	-1,265.75	--	--	-4,935.76
Net Margin (%)	1,778.97	--	-1,168.94	27,712.60	-6,023.34	-2,462.40
Cash Profit Margin (%)	-0.42	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	3.28	-1.00	--	--	-1.00	2.75
EBIT Growth (%)	41.93	-54.34	30.06	23.73	-40.18	-53.03
Net Profit Growth (%)	-188.48	-89.16	35.67	20.72	-35.71	-49.92
EPS Growth (%)	-105.96	-0.66	0.49	0.28	-0.22	0.33
Book Value Growth (%)	-160.75	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-1.44	-2.17	-1.26	-1.39	-8.51
Price / Book Value	17.26	-2.40	-18.52	3.50	2.18	4.02
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.56	-2.00	-1.22	-1.03	-0.96	-6.54
Close Price ($)	0.82	2.51	2.28	2.62	4.01	20.12
High Price ($)	4.56	4.56	5.39	7.25	28.25	34.10
Low Price ($)	0.55	1.11	1.68	1.08	1.87	13.71
Market Cap ($ Cr)	16.15	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-0.71	-0.23	0.04	0.03	--
Short term debt to equity ratio	-0.38	-0.15	-0.11	0.03	0.01	--
Current Ratio	0.10	0.19	0.96	1.05	4.65	7.66
Quick Ratio	0.02	--	0.93	--	--	--
Interest Coverage	-41.48	-242.67	-27.77	--	--	-21,609.12

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	396.83	--	--	--
Asset Turnover	0.01	--	0.05	--	--	0.01
Receivable days	--	--	1,449.40	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.